Good morning. Welcome to today's Colgate-Palmolive 2024 fourth-quarter and year-end earnings conference call. This call is being recorded and is being simulcast live at www.colgatepalmolive.com. Now, ...

Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook. Revenue ...

Consumer companies fell after a mixed round of earnings. Deckers Outdoors plunged after the maker of Hoka- and Ugg-branded shoes posted sales shy of some investors' expectations.

Colgate-Palmolive’s (NYSE: CL) stock faced a downturn as the company’s future guidance failed to align with investor expectations, despite a strong fourth-quarter earnings beat. The personal care ...

Colgate-Palmolive achieved a milestone in 2024, surpassing $20 billion in annual revenue for the first time in its history, ...

Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.

Goldman Sachs analyst Bonnie Herzog maintains a Buy rating on Colgate-Palmolive, with a price target of $106. Despite Q4 EPS of $0.91 exceeding expectations, organic sales growth of 4.3% fell short.

Real-time index price for KBW Regional Banking Index (KRX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Colgate-Palmolive Company CL reported fourth-quarter 2024 results, wherein the top line declined year over year and missed ...

Palmolive forecast annual sales below Wall Street expectations after missing quarterly sales estimates on Friday, hurt by ...

Colgate-Palmolive reported a slight decline in Q4 sales, dropping 0.12% to $4.94 billion, missing estimates. However, organic ...

Prices have likely climbed on a swift move from investors to safety due to Trump tariff threats, rising geopolitical tensions and U.S. government debt, and fear of a potential tech rout that could ...